Currently identified tumor-associated antigens (TAAs) for prostate cancer (PCa) include prostate acid phosphatase (PAP), transient receptor potential (Trp)-p8, prostate-specific membrane antigen (PSMA), prostate stem cell antigen (PSCA), and prostate-specific antigen (PSA) [39]. The gene discussed is PSCA; the disease is posterior cortical atrophy.